A novel amalgamation of 1,2,3-triazoles, piperidines and thieno pyridine rings and evaluation of their antifungal activity

European Journal of Medicinal Chemistry

Volumn 65, Issue , 2013, Pages 527-532

  Darandale, Sunil N ^a   Mulla, Nayeem A ^a   Pansare, Dattatraya N ^a   Sangshetti, Jaiprakash N ^a   Shinde, Devanand B ^a  

^a DR BABASAHEB AMBEDKAR MARATHWADA UNIVERSITY   (India)

Author keywords

1,2,3 triazole; Piperazine and antifungal activity; Thieno pyridine

Indexed keywords

(4 CHLOROPHENYL) [4 [4 [(6,7 DIHYDROTHIENO[3,2 C]PYRIDIN 5(4H) YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL]PIPERIDIN 1 YL]METHANONE; 1 [4 [4 [(6,7 DIHYDROTHIENO[3,2 C]PYRIDIN 5(4H) YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL]PIPERIDIN 1 YL] 2 METHYLPROPAN 1 ONE; 1 [4 [4 [(6,7 DIHYDROTHIENO[3,2 C]PYRIDIN 5(4H) YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL]PIPERIDIN 1 YL]ETHANONE; 1 [4 [4 [(6,7 DIHYDROTHIENO[3,2 C]PYRIDIN 5(4H) YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL]PIPERIDIN 1 YL]PROPAN 1 ONE; 1,2,3 TRIAZOLE DERIVATIVE; 5 [[1 (1 BENZYLPIPERIDIN 4 YL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 4,5,6,7 TETRAHYDROTHIENO[3,2 C]PYRIDINE; 5 [[1 (1 ETHYLPIPERIDIN 4 YL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 4,5,6,7 TETRAHYDROTHIENO[3,2 C]PRYRIDINE; 5 [[1 (1 METHYLPIPERIDIN 4 YL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 4,5,6,7 TETRAHYDROTHIENO[3,2 C]PRYRIDINE; 5 [[1 (1 TOSYLPIPERIDIN 4 YL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 4,5,6,7 TETRAHYDROTHIENO[3,2 C]PYRIDINE; 5 [[1 (PIPERIDIN 4 YL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 4,5,6,7 TETRAHYDROTHIENO [3,2 C]PYRIDINE; 5 [[1 [1 (METHYLSULFONYL)PIPERIDIN 4 YL] 1H 1,2,3 TRIAZOL 4 YL]METHYL] 4,5,6,7 TETRAHYDROTHIENO[3,2 C]PYRIDINE; ANTIFUNGAL AGENT; METHANE; PIPERAZINE; PIPERIDINE DERIVATIVE; THIENOPYRIDINE DERIVATIVE; TOLUENE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; [4 [4 [(6,7 DIHYDROTHIENO[3,2 C]PYRIDIN 5(4H) YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL]PIPERIDIN 1 YL] (PHENYL)METHANONE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG SYNTHESIS; FUNGAL STRAIN; FUSARIUM OXYSPORUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 84879482779     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.04.045     Document Type: Article

References (35)

1. D.P. Kontoyiannis, Lancet 359 (2002) 1135-1144.
2. F.C. Odds, A. Brown, N. Gow, Trends Microbiol. 11 (2003) 272-279.
3. D.L. Hawksworth, Mycol. Res. 105 (2001) 1422-1432.
4. J. Morschhauser, Fungal Genet. Biol. 47 (2010) 94-106.
5. B.K. Srivastava, M. Solanki, B. Mishra, R. Soni, S. Jayadev, D. Valani, M. Jain, P.R. Patel, Bioorg. Med. Chem. Lett. 17 (2007) 1924-1929.
6. S.W. Elmore, C.S. Cooper, C.C. Schultz, D.K. Hutchinson, P.L. Donner, B.E. Green, D.D. Anderson, Q. Xie. WO 01/32655 A2, 2001, Chem. Abstr. 134 (2001) 34037.
7. C.H. Zhou, Y. Wang, Curr. Med. Chem. 19 (2012) 239-280.
8. M.K. Kathiravan, A.B. Salake, A.S. Chothe, P.B. Dudhe, R.P. Watode, M.S. Mukta, S. Gadhwe Bioorg, Med. Chem. 20 (2012) 5678-5698.
9. S. Kallstrom, R. Leino, Bioorg. Med. Chem. 16 (2008) 601-635.
10. Z. Dang, Y. Yang, R. Jia, S. Zhang, Bioorg. Med. Chem. Lett. 17 (2007) 4523-4526.
11. A. Rene, R. Castaigne, U S Patent no. 4,051,141, 1977.
12. R. Sheng, Y. Xu, Q. He, Y. Hu, Eur. J. Med. Chem. 44 (2009) 7-17.
13. S.B. Ravula, J. Yu, G. Beaton, Bioorg. Med. Chem. Lett. 22 (2012) 421-426.
14. G. Aridoss, Y.T. Jeong, Bioorg. Med. Chem. Lett. 18 (2008) 6542-6548.
15. E. Bogatcheva, M. Propova, Bioorg. Med. Chem. Lett. 21 (2011) 5353-5357.
16. M. Matsuoka, T. Kitao, J. Heterocyclic Chem. 29 (1992) 439-442.
17. Y.B. Kim, S.K. Kim, Bioorg. Med. Chem. Lett. 14 (2004) 541-544.
18. L. Gavara, P. Moreau, Eur. J. Med. Chem. 45 (2010) 5520-5526.
19. A. Passannanti, G. Cirrincione, Heterocycles 48 (1998) 1229-1235.
20. M.D. Chen, S.Y. Yang, X.L. Du, Heterocyclic Comm. 6 (2000) 421-426.
21. E.A. Sherement, V. Berestovitsk, Russ. J. Org. Chem. 40 (2004) 594-595.
22. B.S. Holla, N.S. Kumari, Eur. J. Med. Chem. 40 (2005) 1173-1178.
23. A.C. Cunha, E.J. Barreiroa, Bioorg. Med. Chem. Lett. 11 (2003) 2051-2059.
24. K.M. Banu, C. Ananthnarayanan, Ind. J. Pharm. Sci. 4 (1999) 202-205.
25. S. Velarquez, M.J. Camarasa, Antivir. Chem. Chemother. 9 (1998) 481-489.
26. a) J.N. Sangshetti, A.R. Chabukswar, D.B. Shinde, Bioorg. Med. Chem. Lett. 21 (2011) 444-448;
27. (b) J.N. Sangshetti, D.B. Shinde, Eur. J. Med. Chem. 46 (2011) 1040-1044.
28. S.N. Darandale, D.N. Pansare, N.A. Mulla, D.B. Shinde, Bioorg. Med. Chem. Lett. 23 (2013) 2632-2635.
29. R. Cruickshank, J.P. Duguid, B.P. Marmion, R.H. Swain (Eds.), Medicinal Microbiology, second ed., Churchill Livingstone, London, 1975.
30. (a) A.H. Collins, Microbiological Methods, second ed., London, Butterworth, 1976;
31. (b) CLSI, Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Second Informational Supplement. CLSI document M100-S22, Clinical and Laboratory Standards Institute, Wayne, PA, 2012.
32. Z.K. Khan, In vitro and vivo screening techniques for bioactivity screening and evaluation, Proc. Int. Workshop UNIDO-cdri, 1997, pp. 210-211.
33. (a) B. Duraiswamy, S.K. Mishra, V. Subhashini, S.A. Dhanraj, B. Suresh, Ind. J. Pharm. Sci. 68 (2006) 389-391;
34. (b) A.R. Saundane, K. Rudresh, N.D. Satynarayan, S.P. Hiremath, Ind. J. Pharm. Sci. 60 (1998) 379-383;
35. (c) K.L. Therese, H.N. Madhavan, P. Deepa, Ind. J. Med. Microbiol. 24 (2006) 273-279.